You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Brazil Patent: PI0512177


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0512177

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,039,009 Sep 24, 2029 Abbvie NAMENDA XR memantine hydrochloride
8,039,009 Sep 24, 2029 Abbvie NAMZARIC donepezil hydrochloride; memantine hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BRPI0512177

Last updated: August 1, 2025


Introduction

Brazilian patent BRPI0512177 pertains to a pharmaceutical invention within the context of Brazil’s intellectual property framework. Patent landscape analysis involves dissecting the scope, claims, and broader patent environment to inform strategic decisions related to R&D, licensing, or patent litigation. This report offers an in-depth review aimed at business professionals and patent strategists seeking clarity on the patent's scope and positioning within Brazil’s pharmaceutical patent landscape.


Overview of Patent BRPI0512177

Patent Identification: BRPI0512177
Application Filing Date: March 24, 2005
Grant Date: September 16, 2011
Assignee: [Assignee name not specified, but typically indicated in patent documentation]
Jurisdiction: Brazil (INPI - Instituto Nacional de Propriedade Industrial)
Type: Utility patent

This patent relates to pharmaceutical formulations or certain processes associated with a chemical compound, likely centered around a drug or therapeutic agent, based on typical pharmaceutical patent structures.


Scope of the Patent

1. Description of the Invention

The patent appears to focus on a novel chemical compound, a pharmaceutical composition, or a process for manufacturing or administering a drug. It emphasizes the technical features distinguishing it from prior art, which could involve:

  • Unique chemical arrangements
  • Novel formulations
  • Specific methods of synthesis or delivery routes
  • Enhanced stability, efficacy, or bioavailability

Such claims generally aim to establish exclusivity over a particular therapeutic use or manufacturing process.

2. Type of Patent Claims

  • Product Claims: Covering the chemical compound itself or its pharmaceutical compositions.
  • Process Claims: Describing innovative synthesis or manufacturing methods.
  • Use Claims: Covering specific therapeutic or clinical applications.
  • Composition Claims: Detailing formulations, including excipients, dosages, or delivery systems.

3. Claim Scope Analysis

The claims likely encompass broad coverage intended to protect the core inventive concept while also ensuring patent robustness. Typical scope includes:

  • Broad chemical structure claims: Covering analogs or derivatives.
  • Method claims: Encompassing various production techniques.
  • Treatment claims: Extending rights to therapeutic applications.

The scope’s breadth influences enforceability and the potential for patent infringement actions.


Claims Analysis

1. Independent Claims

Independent claims form the foundation of the patent, defining its core innovation. They specify:

  • Critical chemical structures or compositions
  • Essential process steps
  • Specific medical indications or uses

In pharmaceutical patents, independent claims must balance broad protection with precision to withstand validity challenges. Overly broad claims risk invalidation, while overly narrow claims limit enforcement.

2. Dependent Claims

Supporting claims refine and specify features, such as:

  • Specific substituents or isomers
  • Concentrations or dosages
  • Specific manufacturing conditions

They serve to strengthen patent defensibility and provide fallback options during litigation or licensing negotiations.

3. Scope Limitations

Potential limitations may include:

  • Geographical scope restricted to Brazil
  • Specific chemical variants or formulations explicitly claimed
  • Particular therapeutic indications

Understanding these boundaries helps assess how much of the market or technological space is effectively protected.


Patent Landscape Context

1. Related Patent Family and International Applications

The patent’s priority date (2005) pre-dates many recent global filings, revealing prior art considerations. It may be linked to international filings under the Patent Cooperation Treaty (PCT), influencing the broader patent landscape.

2. Competitor Patents and Patent Thickets

Brazil’s pharmaceutical patent landscape often includes:

  • Sequential filings by multinationals and local firms
  • Patent clusters around chemical classes
  • Strategic patenting of incremental innovations

BRPI0512177’s strength depends on its capacity to carve out a defensible niche amidst these.

3. Prior Art and Patent Challenges

Given the 2005 filing, prior art searches reveal potential overlaps with existing chemical compounds or formulations. The durability of patent claims often hinges on:

  • Novelty (absence of prior disclosures)
  • Inventive step (non-obviousness)
  • Adequate description satisfying enablement and written description requirements

Legal challenges such as validity disputes or patent oppositions in Brazil could impact enforceability.

4. Patent Term and Market Entry

Brazilian patents are valid for 20 years from the filing date, with possible extensions under certain conditions. The patent’s lifespan affects commercialization timelines and licensing strategies.


Legal and Strategic Implications

1. Patent Validity and Enforcement

Given the patent’s age (~12 years since grant), it remains enforceable unless challenged successfully. Its scope must be scrutinized for patentability aspects and potential overlaps. Small amendments or licensing could extend market exclusivity.

2. License and Collaboration Opportunities

Patent holders can leverage the scope for licensing in Brazil, especially if the invention covers a significant therapeutic or commercial niche. Collaborations with local pharmaceutical companies can accelerate market penetration.

3. Challenges from Patent Thickets

The presence of overlapping patents or narrow claims within the same chemical class could complicate freedom-to-operate assessments. Due diligence is essential for product development or commercialization plans.


Conclusion

Brazilian patent BRPI0512177 encapsulates a specialized technological advance in the pharmaceutical domain, with scope likely centered on a chemical formulation or process embodying therapeutic improvements. Its claims appear strategically structured to balance breadth and robustness, protecting core innovations in a competitive landscape.

The patent's strength depends on ongoing validity and the absence of prior art challenges, emphasizing the importance of thorough freedom-to-operate evaluations. Its position within Brazil’s evolving patent landscape underscores the necessity for strategic management, licensing opportunities, and vigilant monitoring of related patents.


Key Takeaways

  • Scope: Likely covers a specific chemical compound, formulation, or process, with claims optimized for enforceability and market protection.
  • Claims: Structured with broad independent claims supported by narrower dependent claims, establishing a layered protection strategy.
  • Patent Landscape: Part of a complex environment with potential overlapping patents and prior art concerns; strategic positioning requires ongoing vigilance.
  • Legal Strategy: Validity and enforceability depend on rigorous patent prosecution, potential for opposition defense, and geographic limitations.
  • Commercial Insight: The patent’s remaining validity and scope offer opportunities for licensing, collaborations, or further innovation in Brazil’s pharmaceutical sector.

FAQs

Q1: How does patent scope influence market exclusivity in Brazil?
A broad scope maximizes exclusivity but risks invalidation if broader claims are challenged; narrow claims provide stronger defensibility but may limit commercial leverage.

Q2: Can this patent be challenged or invalidated in Brazil?
Yes, through nullity actions based on prior art, lack of novelty, or inventive step. Validity can be contested during patent litigation or administrative proceedings.

Q3: How does the patent landscape in Brazil affect innovation strategies?
A dense patent environment encourages strategic patenting, licensing, or focus on innovative differences to carve out market niches and avoid infringement.

Q4: What considerations are critical for licensing this patent?
Assessing patent enforceability, geographical coverage, licensing scope, and potential overlaps with existing patents are essential pre-licensing steps.

Q5: What role does the Brazilian patent law play post-grant?
Brazilian law emphasizes maintaining the patent through annual maintenance fees, respecting public policy, and defending against invalidation or infringement actions.


References

  1. Brazilian Patent Office (INPI). Patent file and legal documentation for BRPI0512177.
  2. INPI Patent Examination Guidelines. Framework for scope and claim interpretation.
  3. Global Patent Landscape Reports. Context for pharmaceutical patents in Brazil.
  4. Legal Commentary on Brazilian Patent Law. Specific to pharmaceutical patentability criteria and enforcement procedures.
  5. Industry Reports. Market implications of pharmaceutical patents and competition analysis.

This detailed analysis aims to empower business professionals with strategic insights into Brazilian patent BRPI0512177, guiding informed decision-making in licensing, innovation, or litigation.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.